10.1002/anie.201814331
Angewandte Chemie International Edition
COMMUNICATION
Scheme
1.
Synthesis
of
Enantiopure
α-Arylpiperidine
and
TecnioSpring funding (TECSPR13-1-0040). We are grateful to Dr.
Peter Mꢀller for crystallographic analysis and Dr. Bruce Adams
(MIT) for assistance with NMR structure-determination. We
acknowledge Dr. Andy Thomas, Dr. Scott McCann, Richard Liu and
Dr. Christine Nguyen for assistance in the preparation of this
manuscript.
Tetraisohydroquinoline[a]
Keywords: asymmetric synthesis• copper • hydroamination •
pyrrolidines • benzo-fused nitrogen heterocycles
[1] a) E. Vitaku, D. T. Smith, J. T. Njardarson, J. Med. Chem. 2014, 57,
10257−10274; b) M. E. Welsch, S. A. Snyder, B. R. Stockwell, Curr.
Opin. Chem. Biol. 2010, 14, 347−361. c) R. D. Taylor, M. MacCoss,
A. D. G. Lawson, J. Med. Chem. 2014, 57, 5845−5859.
[2] C. V. Galliford, K. A. Scheidt, Angew. Chem. Int. Ed. 2007, 46,
8748−8758; Angew. Chem. 2007, 46, 8902−8912.
[3] a) J. E. Sieser, M. T. Maloney, E. Chisowa, S. J. Brenek, S. Monfette,
J. J. Salisbury, N. M. Do, R. A. Singer, Org. Process Res. Dev. 2018,
22, 527−534; b) M. Baumann, I. R. Baxendale, C. Kuratli, S. V. Ley,
R. E. Martin, J. Schneider, ACS Comb. Sci. 2011, 13, 405−413.
[4] a) S. M. Banik, A. Levina, A. M. Hyde, E. N. Jacobsen, Science 2017,
358, 761−764; b) S. E. Reisman, A. G. Doyle, E. N. Jacobsen, J. Am.
Chem. Soc. 2008, 130, 7198−7199; c) A. M. d. A. R. Gonsalves, M. E.
d. S. Serra, M. R. Silva, A. M. Beja, J. A. Paixão, L. A. d. Veiga, J.
Mol. Catal. A: Chem. 2001, 168, 53−59.
[a] Isolated yields are reported as the average of two runs. Reaction conditions:
0.50 mmol 4 or 6 (1.0 equiv), Cu(OAc)2 (4.0 mol%), (R,R)-Ph-BPE (4.4 mol%),
DMMS (2.5 equiv), THF (1.0 mL), see the SI for details. [b] No product was
observed using (S)-DTBM-SEGPHOS as the ligand.
Scheme 2. Synthesis of Enantiopure Dibenzo-fused Nitrogen Heterocycles[a]
[5] F. Poordad, F. Felizarta, A. Asatryan, M. S. Sulkowski, R. W.
Reindollar, C. S. Landis, S. C. Gordon, S. L. Flamm, M. W. Fried, D.
E. Bernstein, C.-W. Lin, R. Liu, S. S. Lovell, T. I. Ng, J. Kort, F. J.
Mensa, Hepatology 2017, 66, 389−397.
[6] M. Wang, S. Rule, P. L. Zinzani, A. Goy, O. Casasnovas, S. D. Smith,
G. Damaj, J. Doorduijn, T. Lamy, F. Morschhauser, C. Panizo, B.
Shah, A. Davies, R. Eek, J. Dupuis, E. Jacobsen, A. P. Kater, S. Le
Gouill, L. Oberic, T. Robak, T. Covey, R. Dua, A. Hamdy, X. Huang,
R. Izumi, P. Patel, W. Rothbaum, J. G. Slatter, W. Jurczak, Lancet
2018, 391, 659−667.
[7] a) T. J. Ritchie, S. J. F. Macdonald, S. Peace, S. D. Pickett, C. N.
Luscombe, MedChemComm 2012, 3, 1062−1069; b) C. K. Prier, D.
W. C. MacMillan, Chem. Sci. 2014, 5, 4173−4178.
[8] a) D. C. Blakemore, L. Castro, I. Churcher, D. C. Rees, A. W. Thomas,
D. M. Wilson, A. Wood, Nat. Chem. 2018, 10, 383−394; b) P. S.
Kutchukian, J. F. Dropinski, K. D. Dykstra, B. Li, D. A. DiRocco, E.
C. Streckfuss, L.-C. Campeau, T. Cernak, P. Vachal, I. W. Davies, S.
W. Krska, S. D. Dreher, Chem. Sci. 2016, 7, 2604−2613.
[a] Isolated yields are reported as the average of two runs. Reaction conditions:
0.50 mmol 4 or 6 (1.0 equiv), Cu(OAc)2 (4.0 mol%), (R,R)-Ph-BPE (4.4 mol%),
DMMS (2.5 equiv), THF (1.0 mL), see the SI for details. [b] See SI for detailed
synthetic sequences of azepine and oxazocine analogs. PG = protecting groups.
[9] a) P. Jain, P. Verma, G. Xia, J.-Q. Yu, Nat. Chem. 2017, 9, 140−144;
b) C. J. Cordier, R. J. Lundgren, G. C. Fu, J. Am. Chem. Soc. 2013,
135, 10946−10949; c) G.-H. Hou, J.-H. Xie, P.-C. Yan, Q.-L. Zhou,
J. Am. Chem. Soc. 2009, 131, 1366−1367; d) R. L. LaLonde, B. D.
Sherry, E. J. Kang, F. D. Toste, J. Am. Chem. Soc. 2007, 129,
2452−2453; e) M. C. Wood, D. C. Leitch, C. S. Yeung, J. A. Kozak,
L. L. Schafer, Angew. Chem. Int. Ed. 2007, 46, 354−358; Angew.
Chem. 2007, 119, 358−362; f) A. R. Brown, C. Uyeda, C. A.
Brotherton, E. N. Jacobsen, J. Am. Chem. Soc. 2013, 135, 6747−6749;
g) B. M. Trost, S. M. Silverman, J. Am. Chem. Soc. 2012, 134,
4941−4954; h) N. S. Sheikh, D. Leonori, G. Barker, J. D. Firth, K. R.
Campos, A. J. H. M. Meijer, P. O’Brien, I. Coldham, J. Am. Chem.
Soc. 2012, 134, 5300−5308; i) Z. Cui, H.-J. Yu, R.-F. Yang, W.-Y.
Gao, C.-G. Feng, G.-Q. Lin, J. Am. Chem. Soc. 2011, 133,
12394−12397; j) L. Rajender Reddy, S. G. Das, Y. Liu, M. Prashad,
J. Org. Chem. 2010, 75, 2236−2246; k) For a recent review focus on
the racemic synthesis of saturated N-heterocycles, see: C.-V. T. Vo, J.
W. Bode, J. Org. Chem. 2014, 79, 2809−2815.
Acknowledgements
The authors acknowledge the National Institutes of Health under
Award No. R35-GM122483 for support of the research reported in
this publication and R01-GM058160-17S1 supplemental grant for
the purchase of supercritical fluid chromatography (SFC) equipment.
The content of this publication is solely the responsibility of the
authors and does not necessarily represent the official views of the
National Institutes of Health. X.-J.D. thanks the Canadian National
Science and Engineering Research Council (NSERC) for a
postdoctoral fellowship. O.D.E. thanks the Swiss National Science
Foundation (SNSF) for a postdoctoral fellowship (P2EZP2_175140).
T.L. thanks the Generalitat de Catalunya and ACCIÓ for the
[10] a) D. Hoppe, A. Carstens, T. Krämer, Angew. Chem. Int. Ed. 1990, 29,
1424−1425; Angew. Chem. 1990, 102, 1455−1456; b) D. Hoppe, T.
This article is protected by copyright. All rights reserved.